Exact Sciences Corp (EXAS) Reports In-Line Q3 EPS Loss of $0.15

Exact Sciences Corp (NASDAQ: EXAS) reported Q3 EPS of ($0.15), in-line with the analyst estimate of ($0.15). Revenue for the quarter came in at $1.03 million versus the consensus estimate of $1.03 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance